Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
What factors will most influence your decision to offer ENCELTO to patients with macular telangiectasia type 2?
Related Questions
What factors influence the decision between anti-VEGF injections and surgical displacement with tPA for treating submacular hemorrhage in AMD patients?
What long-term complications have you observed in previously stable preterm infants with incomplete peripheral retinal vascularization who did not undergo ROP laser treatment?
When should delayed removal of an intraocular foreign body be considered?
How do you incorporate intravitreal methotrexate injections into the management of traumatic retinal detachment repairs?
What guides reoperation versus observation in managing macular folds after retinal detachment surgery?
Would you recommend observation or laser retinopexy in a young myope with asymptomatic lattice degeneration with retinal holes within lattice in each eye?
What’s your approach to managing postoperative inflammation and CME in high-risk patients after cataract surgery?
How do you typically manage the use of intravitreal antibiotics during globe repair?
In eyes with lamellar macular holes, what clinical or OCT features push you toward recommending surgery versus continued observation?
What factors influence your evaluation of surgical candidacy for persistent fetal vasculature, and how do you approach operative management?
